The Sterile Medical Laser Fiber segmentation by application delineates six primary clinical domains: Ophthalmology, Dermatology, Urology, Gynecology, Ear‑Nose‑Throat (ENT), and General Surgery. Ophthalmology commands the largest share, driven by high‑volume cataract and refractive procedures that require precise, low‑loss fibers, contributing roughly 30 % of total revenue. Dermatology follows at 25 %, reflecting extensive use in laser skin resurfacing, hair removal, and vascular lesion treatments where disposable sterile fibers dominate cost structures. Urology accounts for 15 % as laser lithotripsy and tissue ablation rely on robust fibers compatible with high‑energy pulses. Gynecology, at 10 %, is shaped by hysteroscopic and endometrial ablation applications, where fiber sterility mitigates infection risk. ENT procedures, representing 12 %, include laser tonsillectomy and airway management, requiring fibers with flexible diameters. General Surgery, contributing the remaining 8 %, encompasses miscellaneous laser‑assisted interventions such as tumor excision and vascular sealing, where fiber selection is driven by procedure‑specific wavelength and power needs. Collectively, these application categories define the market’s demand profile and guide product development priorities.